Ottawa maintains C$500 million annually for rare diseases
Long-term funding for other care remains under discussion.
Carried forward October 20. October 16 meeting and commitments.
In Winnipeg on October 16, Ottawa confirmed continued annual funding of C$500 million for the National Strategy for Drugs for Rare Diseases. [1]
Two separate commitments
The Canadian Press reports that this funding was due to expire in 2027. Ottawa is also extending C$1.2 billion in annual funding for mental health, addictions and home care by one year. [2]
Further negotiations
Ministers will continue discussing sustainable federal funding and meet again before the end of 2026. Quebec and British Columbia are not parties to the statement. [1]
A transition measure
Health Minister Marjorie Michel tells The Canadian Press that the one-year extension helps bridge the transition to the federal fall budget schedule. [2]
Perspectives compared
Sources and documents
- [1] Health Canada — ministers’ statement ↗October 16, 2026
- [2] The Canadian Press — Ian Bickis / iNFOnews ↗October 16, 2026, 3:46 p.m. displayed